Riboflavin is thoroughly established to be indispensable in a multitude of cellular oxidation-reduction reactions through its conversion to coenzyme forms flavin mononucleotide and flavin adenine dinucleotide. Despite its physiological importance, little is known about specific mechanisms or proteins involved in regulating its cellular entry in humans. Studies involving biochemical modulators and immunological inhibition assays have indirectly revealed that riboflavin internalization and trafficking occurs at least in part through a clathrin-dependent receptormediated endocytic process. Here, using a two-tiered strategy involving RNA interference and the overexpression of dominant-negative constructs, we directly show the involvement of this endocytic mechanism through the requirement of the pluripotent endocytic vesicle scission enzyme, dynamin 2 GTPase, in human placental trophoblasts. Similar to the endocytic control ligand, transferrin, riboflavin is shown to exhibit 50% dependence on the functional expression of dynamin 2 for its active cellular entry. Furthermore, this reduced vitamin uptake correlates with Ͼ2-fold higher riboflavin association at the cell surface. In addition, fluorescent ligand endocytosis assays showing colocalization between rhodamine-riboflavin and the immunostained caveolar coat protein, caveolin 1, suggest that the active absorption of this important nutrient involves multiple and distinct endocytosis pathways.
Endocytosis is a cellular absorption mechanism that serves as a major route for nutrient and macromolecule entry intrinsic to prokaryotic and eukaryotic cells to promote growth, maintenance, and function. Receptor-mediated endocytosis (RME) selectively internalizes specific ligands and commonly depends on clathrin as an accessory coat protein. Clathrindependent RME (CME) has been characterized to regulate the absorption and trafficking of a variety of ligands, including transferrin, low-density lipoprotein, and tumor growth factor ␤ (TGF-␤) (van der Ende et al., 1987; Fielding and Fielding, 1996; Di Guglielmo et al., 2003) . In light of the restrictive nature of this uptake process, drug bioavailability can be significantly improved by targeting therapeutics to such absorption mechanisms. In combination with drug stabilizing agents and biochemical modulators to promote targeting to cellular organelles, a substantial increase in membrane permeability of hydrophilic drugs and macromolecules can be achieved, as well as enhanced cellular retention by circumventing efflux transporters (Sheff, 2004) . The transferrin pathway, which regulates iron homeostasis, has been a pivotal portal for targeting chemotherapeutics to various tumors that have higher demands for iron over normal cell populations (Daniels et al., 2006) . It is noteworthy that the successful design of drug-targeting strategies and therapeutic applications can only occur upon thorough molecular characterization of ligand-associated RME systems. The molecular sensors regulating riboflavin (vitamin B 2 ) homeostasis is a relatively unexplored pathway that has gained recent attention for its proposed importance in fetal development and breast and liver cancer physiology (Zempleni et al., 1995; Rao et al., 1999 Rao et al., , 2006 . Vitamin B 2 is an essential nutrient required by oxidation-reduction pathways critical in normal cellular growth, function, and maintenance. States of physiological B 2 deficiency have been correlated with clinical manifestations including cardiovascular disease, stunted growth, anemia, and neurodegeneration (Powers, 2003 (Powers, , 2005 . Despite its clinical and physiological value, the cellular mechanism(s) regulating B 2 absorption is poorly defined. Recent reports suggest that one portal of entry for B 2 may involve CME Swaan, 2000, 2001; Huang et al., 2003; D'Souza et al., 2006b ). These studies demonstrated cytoskeletal dependence and clathrinand/or Rab5-positive endosomal enrichment of B 2 in placental trophoblasts (BeWo). Because both clathrin and Rab5 are endocytic markers of CME, these data suggest that B 2 absorption involves CME. Furthermore, analogous to the wellcharacterized CME ligand, transferrin, a B 2 carrier protein has been proposed to sequester free extracellular B 2 and facilitate its transport to endosomal organelles (Mason et al., 2006) . Although such a soluble carrier protein has been characterized in oviparous species (Abrams et al., 1988; Zheng et al., 1988) , the identity of a human homolog remains elusive.
A major limitation to the B 2 -RME model is a lack of direct evidence identifying the functional dependence on critical proteins regulating this nutrient absorption mechanism in humans. Dynamin 2 is a candidate protein regulator of cellular B 2 levels. Dynamin 2 (DNM2) is a ubiquitously expressed GTPase known to regulate the invagination and constriction of vesicles at the plasma membrane and trans-Golgi domain of mammalian endothelial and epithelial cells (Hill et al., 2001; Conner and Schmid, 2003) . It is required by multiple endocytic mechanisms including those pathways dependent on clathrin or caveolin, and consequently it has been described as the "master regulator of membrane trafficking events at the cell surface" (Conner and Schmid, 2003) . Based on prior studies suggesting a B 2 -CME mechanism occurring in the placental trophoblast model (Huang et al., 2003; D'Souza et al., 2006a,b) , we hypothesized that B 2 internalization requires dynamin 2 GTPase. Using the established BeWo system, a two-tiered approach involving RNAi and transient transfections of a GTPase-null (K44A) dynamin 2-expression construct was carried out to elucidate the role of this enzyme in B 2 RME.
To date, the proposed B 2 -RME model has been defined exclusively by the involvement of the CME mechanism in humans. However, other distinct RME pathways have been shown to be critical in nutrient absorption. Folate uptake is documented to occur through caveolae-mediated endocytosis (CvME) in addition to CME (Birn, 2006) . Furthermore, prior data that revealed B 2 enrichment to Rab5 GTPase-positive endosomes in human placental trophoblasts and enterocytes (D'Souza et al., 2006b ) may reflect a CvME trafficking mechanism. Recent reports have implicated the potential for crosstalk in cargo transport between caveosomes (i.e., an organelle specific to CvME) and Rab5-positive vesicles of CME (Querbes et al., 2006) . Thus, it becomes plausible that B 2 -RME may involve multiple endocytic pathways. The involvement of CvME in B 2 trafficking in BeWo cells was determined using 3D fluorescence colocalization analyses between internalized rhodamine-labeled B 2 (Phelps et al., 2004 ) and immunostained caveolin 1 (i.e., a CvME membrane coat protein).
Overall, the objectives of this study were to define the general extent by which B 2 absorption depends on endocytosis as a function of the expression level of the major vesicle scission protein, dynamin 2 GTPase, and evaluate whether B 2 -RME involves the CvME pathway in human placental trophoblast cells. Results from this study are the first to directly reveal the dependence of B 2 absorption on dynamin 2 expression in human epithelia and demonstrates, in addition to CME, the involvement of CvME in intracellular B 2 trafficking.
Materials and Methods
Cell Culture. Human placental trophoblasts (BeWo, passages 205-220) were routinely maintained in a controlled atmosphere at 37°C with 5% CO 2 in F-12K culture media (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum, 1% nonessential amino acids, 100 U/ml penicillin, and 100 g/ml streptomycin. All transfection treatments were tested for cytotoxic effects on cell viability using the lactate dehydrogenase-based CytoTox-ONE assay according to manufacturer's instructions (Promega, Madison, WI). All chemicals used in these studies were purchased from Sigma (St. Louis, MO) unless stated otherwise.
Duplex Short-Interfering RNA Transient Transfection. Cells grown to ϳ50 to 60% confluence were seeded (4.2 ϫ 10 4 cells/ cm 2 ) onto 24-well plates using antibiotic-free F-12K media. Twentyfour hours later, cells were briefly washed and preincubated in serum-free and antibiotic-free Opti-MEM I media (Invitrogen) for ϳ2 h at 37°C and under 5% CO 2 . After this incubation, cells were transfected in Opti-MEM I media with 20 or 40 nM concentration of 21-mer duplex short-interfering RNA (siRNA) complexed with Lipofectamine 2000 [1.5% (v/v)] according to the manufacturer's instructions (Invitrogen). Cells were incubated with siRNA-lipid complexes at 37°C and 5% CO 2 for 6 h, at which time the transfection media was replaced with normal F-12K media lacking antibiotics. Cells were used in experiments 48 to 72 h after transfection. All RNA interference studies involved the use of experimentally validated duplex siRNA targeting the human dynamin 2 gene (DNM2 pool siGenome Smartpool, GenBank accession no. NM_004945; Dharmacon RNA Technologies, Chicago, IL) and human dynamin-like protein 1 (DLP1; GenBank accession no. NM_012063; QIAGEN, Cambridge, MA). Targeting siRNA effects were normalized to cells transfected with equivalent amounts of nontargeting duplex siRNA (siControl NonTargeting siRNA; Dharmacon RNA Technologies) and compared with mock (Lipofectamine 2000 alone) and untreated cell conditions. Western Blotting and Chemiluminescence-Based Densitometry. Whole cells transfected 63 to 68 h earlier with siRNA were harvested and lysed on ice for 20 min in radioimmunoprecipitation assay buffer [10 mM Tris-HCl, pH 7.5, 140 mM NaCl, 1% (v/v) Triton X-100, 1% (w/v) sodium deoxycholate, and 0.1% (w/v) SDS] supplemented with a Complete Mini protease cocktail tablet according to manufacturer's instructions (Roche Diagnostics, Indianapolis, IN). Total protein (10-15 g) was resolved on 12.5% Tris-HCl Criterion gels (Bio-Rad Laboratories, Hercules, CA), transferred to polyvinylidene difluoride membranes, and immunoblotted using monoclonal antibodies specific to dynamin 2 (final concentration, 0.15 g/ml; Calbiochem, San Diego, CA) or dynamin-like protein 1 (final concentration, 0.25 g/ml; BD Pharmingen, San Diego, CA). Primary antibodies were subsequently labeled with horseradish peroxidase-conjugated IgG [1:20,000 (v/v) working dilution; GE Healthcare, Chalfont St. Giles, Buckinghamshire, UK] and detected using the ECL plus system (GE Healthcare). Protein levels were quantitated using chemiluminescence-based densitometry on a chemi-doc universal hood II system (Bio-Rad Laboratories) and normalized to the corresponding housekeeping protein expression for either glyceraldehyde-3-phosphate dehydrogenase (final concentration, 2 g/ml; Ambion Inc., Austin, TX) or ␤-actin (final concentration, 2.4 g/ml; Sigma-Aldrich). (Cao et al., 1998) . Before transfections, both plasmids were transformed into DH5-␣ cells (Invitrogen), subcultured in Luria broth with ampicillin selection, and purified using the Plasmid Maxi Kit (QIAGEN). Expression vector identities were confirmed through restriction enzyme digests and sequencing using the following established dynamin 2 primers: forward primer, [5Ј-GAAGAGGGCCAT-ACC-3Ј]; and reverse primer, [5Ј-AGTTGCGGATGGTCTC-3Ј] (Cao et al., 1998) . Cell seeding conditions were maintained as in RNAi studies. Twenty-four hours after seeding, cells were briefly washed and preincubated in serum-free and antibiotic-free Opti-MEM I for 2 h at 37°C and under 5% CO 2 . Cells were transfected using Opti-MEM I with 400 ng of plasmid DNA alone or with 40 nM DNM2 pool siRNA and complexed with Lipofectamine 2000 [1.5% (v/v)]. Cells were exposed to these transfection complexes for 6 h at 37°C and under 5% CO 2 . Thereafter, the transfection media were replaced with complete F-12K media devoid of antibiotics. Cells were used in experiments 48 to 72 h after transfection.
Radiolabeled Ligand Endocytosis Assays. I]TF was determined using liquid scintillation-or ␥ counting, respectively. Both plasma membrane-bound and internalized radiolabeled ligands were normalized to total protein content using the Bradford assay (Bio-Rad). All [ 3 H]B 2 uptake data generated at 37°C was corrected for passively absorbed B 2 that was approximated by performing parallel uptake assays exclusively at 4°C. Actively internalized B 2 (i.e., uptake at 37°C) was defined by subtracting internalized [ 3 H]B 2 at 4°C. Acid wash samples collected after uptake assays represented plasma membrane-bound ligands and were compared with internalized samples using the following equations:
The extent of bound ligand was expressed as a percentage of the sum of bound (b e ) and absorbed (i e ) ligand under experimental conditions and was normalized to the percentage of bound ligand under nontargeting conditions (b nt ) (eq. 1). Likewise, the extent of absorbed ligand (i e ) was defined as a percentage of bound plus internalized ligand under experimental conditions and then was normalized to nontargeting effects (i nt ) (eq. 2). Fluorescent Ligand Endocytosis Assay and Immunofluorescence Staining. BeWo cells were seeded 3 to 5 days before experiments (5 ϫ 10 3 cells/cm 2 ) in collagen-coated BD Falcon culture slides (BD Biosciences, Bedford, MA). After serum starvation for 2 h, pulse-chase assays with 500 nM rhodamine-riboflavin (Rd-RF) (Phelps et al., 2004) , 15 nM Alexa Fluor 555-labeled cholera toxin subunit B (CTX; Invitrogen), or 30 nM 5-carboxytetramethylrhodamine-labeled transferrin (TF; Invitrogen) were carried out according to established methods (Huang et al., 2003; D'Souza et al., 2006b) . Cells were dosed with the fluorescent ligands for 2 or 10 min at 37°C and then immediately fixed with 4% paraformaldehyde for 20 min at room temperature. The fixed cells were then permeabilized for 20 min with 0.1% Triton X-100 in PBS with Ca 2ϩ and Mg 2ϩ , pH 7.4. Permeabilized cells were blocked with 3% (w/v) bovine serum albumin in PBS, pH 7.4, for 30 min before 1-h immunolabeling for either caveolin 1 with rabbit-anti-caveolin 1 (CAV1) [1:500 (v/v) final dilution; Sigma] or clathrin (final concentration, 1 g/ml; BD Biosciences). Cells were thoroughly washed with bovine serum albumin/ PBS and probed with Alexa Fluor 405-labeled goat-anti-rabbit-or sheep-anti-mouse IgG [1:400 (v/v) final dilution; Invitrogen]. Fluorescence treatments were preserved using GelMount (Biomeda Corporation, Foster City, CA) and kept at Ϫ20°C until used in fluorescence imaging.
3D Confocal Laser Scanning Microscopy and Colocalization Analysis. Internalized fluorescent ligands and immunostained endocytic marker proteins, caveolin 1 and clathrin, were imaged using a Nikon Eclipse TE2000 E inverted confocal laser scanning microscope (Nikon Instruments Inc., Melville, NY) outfitted with fixed lasers for 405 and 543 nm and corresponding emission filters of 450/35 and 605/75 nm, respectively. Three-dimensional images were acquired using the following settings on Nikon EZ-C1 software (Gold version 2.3; Image Systems Inc., Columbia, MD): Nikon plan apochromatic 60ϫA oil objective (1.4 numerical aperture), 3.6-s scan dwell time, 512 ϫ 512 pixel size resolution, 0.30 m z-step, and a 150-m detector pinhole. Raw images were iteratively deconvolved using a calculated point-spread function for individual channels and corrected for background noise using a combination of median filtration and setting threshold levels just greater than negative control treatments with either a nonreactive rhodamine derivative (carboxytetramethylrhodamine-4-amine, a byproduct of the rhodamineriboflavin conjugation reaction; Phelps et al., 2004) or the secondary Alexa Fluor 405 antibody alone. Restored images were analyzed for 3D colocalized fluorescence between ligands and endosome markers using Volocity, version 3.6.1 (Improvision Inc., Lexington, MA). The extent of colocalization between ligands and endocytic markers was determined by calculating the percentage of total overlap volume (in cubic micrometers) over the corresponding total ligand volume.
Statistics. One-way ANOVA with Dunnett's or Neuman-Keuls multiple comparison tests were used to define statistical significance between the effects of targeting siRNA or wild-type and dominantnegative dynamin 2 construct treatments and control conditions (i.e., nontargeting siRNA, empty vector, mock, and untreated treatments) on ligand trafficking. Statistical significance between the effects of targeting siRNA and controls (i.e., nontargeting siRNA or untreated conditions) on dynamin protein levels was defined using the nonparametric Student's t test. True fluorescence colocalization between channels for fluorescent ligands and immunostained endocytic markers was defined using the Pearson's correlation (Manders et al., 1993) .
Results
siRNA Targeting Dynamin 2 or Dynamin-Like Protein 1 Resulted in Specific Protein Knockdown While Maintaining Cell Viability. In addition to the use of nontargeting siRNA treatments and to clearly validate siRNA specificity, all RNAi transient transfection studies included external control conditions involving siRNA targeting a dynamin homolog, DLP1. Like DNM2, DLP1 is a member of the dynamin superfamily (Praefcke and McMahon, 2004) and shares ϳ36% sequence homology to DNM2. In contrast to DNM2, DLP1 is not involved in endocytic vesicle scission events, and has been largely characterized to function in the morphological maintenance of peroxisomes and mitochondria (Praefcke and McMahon, 2004) . Based on the current understanding of DLP1, we hypothesized that this protein is not involved in the endocytosis of B 2 .
BeWo cells were transiently transfected with 20 or 40 nM targeting siRNA for dynamin 2 GTPase (DNM2 pool) or DLP1. Cells were harvested 63 to 68 h after initiating siRNA transfections and analyzed for target dynamin knockdown using immunoblotting and chemiluminescence-based densitometry. Upon normalization to housekeeping protein levels, the extent of dynamin expression was defined as a percentage of detected dynamin in cells treated exclusively with nontargeting siRNA (N). Parallel cell populations that were treated with the lipid transfection reagent (Mock) or untreated cells served as additional negative controls. Twenty and 40 nM DNM2 pool siRNA treatments substantially reduced dynamin 2 (100 kDa) expression levels to a similar extent (Fig. 1A) . However, 20 and 40 nM DLP1 siRNA specifically knocked down DLP1 protein (83 kDa) expression in a dose-dependent manner (Fig. 1B) . The lack of a dose-dependent effect on dynamin 2 expression with the DNM2 pool siRNA conditions may reflect a more robust siRNA formulation, which involves the coadministration of four different duplex siRNAs targeting different regions of the DNM2 mRNA. Quantitative densitometry revealed that 40 nM DNM2 pool siRNA treatments led to ϳ78% (21.95 Ϯ 7.03% N) and ϳ82% lower dynamin 2 GTPase levels compared with nontargeting siRNA-treated and untreated cells, respectively (Fig. 1C) . To a similar extent, 40 nM DLP1 siRNA conditions resulted in ϳ62% (37.65 Ϯ 11.13% N) and ϳ63% lower DLP1 protein levels compared with nontargeting siRNA and untreated conditions, respectively (Fig. 1D) . Neither of the dynamin siRNA treatments revealed significant off-target effects at the protein level. Furthermore, dynamin protein levels were shown to be similar between nontargeting siRNA treatments and untreated cell conditions. These data suggest that the negative control siRNA transfection effects are not significantly altering target protein levels and serves as a valid reference for targeting siRNA data normalization.
Cell viability under all transfection treatments was examined for potential cytotoxic effects as a function of lactate dehydrogenase release. Cells treated with the various siRNA conditions, plasmid transfections, and mock-transfected cell populations were tested for lactate dehydrogenase release 48 h after transfection. No significant cell death was revealed for any of the transfection treatments, and cell viability for these conditions was at or near those measured for untreated BeWo cells (data not shown). Taken together, these data indicate that siRNA treatments at the 40 nM dose specifically knock down target dynamin proteins without compromising cell viability and justify the RNAi methodology.
Silenced Dynamin 2 Resulted in a Significant Reduction in [ 3 H]B 2 Internalization at Physiological Temperatures. It has been well-established that B 2 gains entry into human epithelial cells via multiple mechanisms, including a passive diffusion component that seems to dominate at oversupplemented riboflavin levels and an active component that has been reported to coincide with micromolar B 2 concentrations (Foraker et al., 2003) . One of the salient features defining an active absorption mechanism is temperaturedependence. Saturable absorption kinetics have been consistently shown to correlate with physiological temperatures (ϳ37°C), whereas low temperatures (ϳ4°C) generate linear absorption profiles reflecting passive diffusion (Said and Ma, 1994) . In fact, B 2 transport has been reported to be dependent on temperature in divergent cell models (Said and Ma, 1994; Huang and Swaan, 2001 ). However, temperature-dependence alone does not discriminate between a carrier/ transporter and receptor-mediated endocytic process. Therefore, to differentiate between such active uptake mechanisms, the standardized RNAi methods involving siRNA-induced silencing of the conserved endocytic protein, dynamin 2 GTPase, in combination with the effects of temperature change on B 2 absorption were investigated. To date, the human placental trophoblast cell model (BeWo) has been shown to express high affinity for riboflavin (ϳ2 nM) (Huang and Swaan, 2001) , and such nanomolar affinities further suggest the involvement of RME in this vitamin's cellular uptake. Combined with prior reports suggesting a B 2 -specific RME absorption process (Huang and Swaan, 2001; Huang et al., 2003; D'Souza et al., 2006a,b) , these data validate the utility of the BeWo cell model to characterize the B 2 -specific RME pathway(s). BeWo cells transfected with 40 nM targeting or nontargeting siRNA 63 to 72 h prior were used in endocytosis assays. Transiently transfected cells were dosed with 5 nM [ 3 H]B 2 for 4 min at 4 or 37°C. The 4-min internalization period was chosen for all endocytic assays because this is the characterized time interval coinciding with the logarithmic uptake phase typical of RME mechanisms (Schmid, 2004) . Passively diffusing riboflavin was defined by vitamin uptake detected at 4°C. Actively internalized B 2 was determined by the amount of B 2 absorbed at 37°C minus that absorbed at 4°C. For the remainder of this report, all actively internalized B 2 data shown represents the active absorption component exclusively. In contrast to all other transfection conditions, DNM2 pool siRNA-induced silencing of dynamin 2 GTPase resulted in a significant reduction of 50% (i.e., 0.18 Ϯ 0.11 S.D. and 0.37 Ϯ 0.09 S.D. pmol/mg of protein/4 min for DNM2 pool siRNA-treated and untreated cells, respectively) in actively absorbed B 2 compared with internalized B 2 in untreated cell populations ( Fig. 2A) . As expected, passively diffusing B 2 (i.e., uptake at 4°C) was unaffected by all transfection conditions (Fig. 2B) . Collectively, these results further substantiate the involvement of classic RME machinery (i.e., dynamin 2 GTPase) in regulating the active absorption of B 2 in placental trophoblasts.
Iodinated transferrin ([ 125 I]TF or TF) was chosen to serve as a positive control ligand in all endocytosis assays. Transferrin is an iron carrier protein that has been thoroughly characterized to be internalized via the classic clathrin-dependent endocytic pathway, which is known to be regulated by dynamin 2 expression in A431 cells (Lamaze et al., 1993) . Thus, transferrin uptake is expected to be significantly inhibited under DNM2 pool siRNA treatments. BeWo cells were transiently transfected with 40 nM targeting or nontargeting siRNA 63 to 72 h before performing uptake assays. Cells were then dosed with either 5 nM [ 3 H]B 2 or 10 nM [ 125 I]TF for 4 min at 37°C. The effects of all treatments, including mock and untreated conditions, on ligand absorption were defined as the percentage of nontargeting siRNA effects. It is interesting that both actively internalized B 2 and TF were significantly reduced to a similar extent exclusively under silenced dynamin 2 states. Riboflavin internalization was reduced by ϳ40% (59.45 Ϯ 24.70% S.D. of N; Fig. 3A) , and transferrin absorption was reduced by ϳ30% (69.64 Ϯ 4.27% S.D. of N; Fig. 3B ). The attenuation in transferrin uptake seen exclusively with DNM2 pool siRNA-treated cells is in agreement with literature reports revealing this ligand's dependence on CME and dynamin 2 expression (Cao et al., 2003) and further validates the specificity of the RNAi methodology. A similar effect on B 2 absorption under these same . Actively internalized B 2 (uptake at 37°C) was determined by subtracting passively absorbed riboflavin (uptake at 4°C). These data represent the standard deviations of three to five separate experiments. Statistical significance between targeting and nontargeting treatments was defined using one-way ANOVA with Newman-Keuls multiple comparison test ‫,ء(‬ p Ͻ 0.05). 
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at ASPET Journals on April 2, 2017 molpharm.aspetjournals.org conditions further corroborates prior evidence suggesting that this vitamin is internalized via CME Swaan, 2000, 2001; Huang et al., 2003; Phelps et al., 2004; D'Souza et al., 2006a,b; Mason et al., 2006) . Furthermore, the reduced absorption of B 2 (40%) directly correlated with ϳ80% reduced protein expression for DNM2 (Fig. 1C) . Thus, we can approximate that at least 50% of the active component regulating B 2 absorption in human placental trophoblasts requires dynamin 2-dependent RME events.
B 2 Enrichment at the Plasma Membrane Doubled under Silenced Dynamin 2 States. Dynamin 2 GTPase has been extensively characterized to function as a critical gate keeper of intracellular trafficking in that it is required in endosomal vesicle formation and release from the plasma and Golgi membranes (McNiven et al., 2000) . Without functional dynamin 2, RME mechanisms such as clathrin-dependent RME are prevented from forming endosomal vesicles and thus are unable to transport their cargo from the plasma membrane or Golgi domain to various other destinations in the cell. Instead, ligand-bound receptors are restricted to these membranes. In light of the evidence of attenuated uptake for both B 2 and TF shown exclusively under silenced dynamin 2 treatments, we would expect a concomitant increase in ligand concentrations bound at the cell surface. To test this hypothesis, we analyzed the extent of plasma membrane-bound ligand detected after the 4-min uptake period and compared these data with the extent of the internalized ligand.
Membrane-bound and internalized ligands detected under the varying 40 nM siRNA treatments were normalized to nontargeting siRNA effects and were expressed using eqs. 1 and 2 defined under Materials and Methods. As expected, DNM2 pool siRNA treatments led to a more pronounced increase in the extent of bound B 2 at the plasma membrane, which coincided with a concomitant decease in its internalization. Likewise, plasma membrane TF localization was enhanced under silenced dynamin 2 conditions. In particular, under silenced dynamin 2 states, plasma membrane-bound B 2 was shown to be ϳ150% higher than bound ligand revealed for untreated cells (Fig. 4A) . In addition, internalized B 2 reduced by ϳ40% compared with untreated conditions. Although to a lesser extent than that shown for B 2 , membrane-bound TF detected for cells treated with DNM2 pool siRNA increased ϳ110% over bound ligand detected in untreated cell populations (Fig. 4B) . Furthermore, TF uptake reduced ϳ30% under attenuated dynamin 2 levels compared with untreated cells. Both B 2 and TF showed substantial localization at the plasma membrane with dynamin 2-silenced treatments compared with the corresponding internalized ligand data. Both ligands revealed nearly 200% higher enrichment at the plasma membrane than within the cell. In addition, when the extent of bound over the extent of internalized ligand was expressed as a ratio, both B 2 and TF were shown to be 3.1-and 2.0-fold higher than that defined for untreated conditions, respectively (Fig. 4, C and D) .
B 2 Was Substantially Enriched at the Membrane Surface in Cells Transiently Transfected with GTPaseNull Dynamin 2 (K44A).
A common approach in corroborating RNAi data involves the use of wild-type and dominantnegative expression vectors. We obtained fully characterized DNM2
WT and DNM2 K44A expression constructs, the latter of which is unable to hydrolyze GTP and thus unable to pinch off nascently formed endocytic vesicles at the plasma membrane (Cao et al., 1998 and TF results were expressed as a ratio of plasma membrane-bound ligand over internalized ligand, a strikingly similar trend was revealed (Fig. 5) . Both ligands were shown to be largely localized at the cell membrane, as opposed to the intracellular environment, under GTPase-null dynamin 2 alone and cotransfection conditions (i.e., DNM2 K44A or DNM2 siRNA ϩ 
DNM2
K44A , respectively). Although not significant, plasma membrane bound B 2 under GTPase-null dynamin 2 conditions was shown to increase 1.5-and 1.7-fold over cells transfected with wild-type dynamin 2 or the empty vector alone, respectively (Fig. 5A) . The enhanced enrichment of B 2 to the membrane surface was shown to be more pronounced under cotransfection conditions (i.e., DNM2 siRNA ϩ DNM2 K44A ), which led to 1.8-, 2-, and 1.4-fold higher membrane localization compared with the effects of wild type, the empty vector, and the cotransfection treatment involving nontargeting siRNA and the empty vector, respectively. A similar trend was noted for the control ligand, transferrin. Transient transfections involving GTPase-null dynamin 2 revealed nearly 2-and 2.4-fold higher TF localization at the plasma membrane versus the effects of wild-type dynamin 2 and empty vector treatments, respectively (Fig. 5B) . Similar to B 2 , the cotransfection condition led to a more pronounced enrichment of TF at the membrane surface that was 1.5-and nearly 3-fold higher than the effects of the negative control cotransfection treatment (i.e., N siRNA ϩ empty vector) and the empty vector, respectively. These results are in agreement with the data from cells transfected with DNM2 pool siRNA alone and provide additional evidence that actively internalized B 2 requires, in part, the functional expression of the highly conserved mechanoenzyme, dynamin 2, for its endocytic translocation in human placental trophoblasts.
Rhodamine-Labeled-B 2 Colocalized with the Caveolae Coat Protein Caveolin 1. CAV1 is characterized to function in caveolae-mediated endocytosis in mammalian cells (Pelkmans et al., 2004) . Specifically, CAV1 is a cytoplasmically oriented integral membrane protein known to bind cholesterol (Uittenbogaard and Smart, 2000) and associates with cholesterol-and sphingolipid-rich plasma membrane domains termed caveolae. CAV1 is one of three known caveolin isoforms that has been characterized to be critical in signal transduction pathways, membrane organization, and ligand bound receptor-mediated trafficking specific to CvME in many divergent cell systems (Cheng et al., 2006) . Some of the classic ligands that have been characterized to be absorbed and trafficked via this pathway include cholera toxin subunit B and folate (Shajahan et al., 2004; Birn, 2006) . Furthermore, like CME, CvME is dependent on dynamin 2 for vesicle formation and release from the plasma membrane (Yao et al., 2005) .
Internalized Rd-RF, Alexa Fluor 555-labeled CTX, or 5-carboxytetramethylrhodamine-labeled TF were examined for colocalization with immunofluorescence detected endosome markers, CAV1 or clathrin, in BeWo cells. All fluorescence colocalization assessments were further analyzed for intact cell morphology using differential interference contrast imaging (data not shown). After a 2-min uptake period, both Rd-RF and CTX resulted in punctate staining resembling endosomal organelle localization (Fig. 6A) . Similar to CTX, Rd-RF resulted in substantial overlap with CAV1. However, signal overlap between Rd-RF and CAV1 resulted in a largely peripheral cytoplasmic staining pattern compared with the perinuclear staining noted for colocalized CTX and CAV1 channels. In addition, Rd-RF and the positive control ligand, transferrin, revealed punctate, perinuclear signal overlap with clathrin-positive endosomes after this same time period (Fig. 6B) .
With the objective of defining the degree of involvement of these distinct endocytic pathways in B 2 intracellular trafficking, the extent of colocalization between ligands and the endocytic markers was defined as the percentage of the total detected ligand volumes (in cubic micrometers) and represents 2-and 10-min internalization periods (Fig. 7A) . It is interesting that Rd-RF revealed the greatest extent of colocalization at the 2-min time point and resulted in a similar degree of overlap with both endocytic markers (20.77 Ϯ 13.30% S.E.M. for overlap with clathrin vesicles and 34.40 Ϯ 9.36% S.E.M. for overlap with caveolin 1 vesicles). Likewise, TF revealed maximal clathrin-endosome localization for the shortest uptake period (26.05 Ϯ 13.84% S.E.M.). However, CTX revealed increasing ligand buildup to caveolin 1-positive endosomes with maximal colocalization after 10 min (39.16 Ϯ 10.07% S.E.M.). Combined, these data reveal B 2 trafficking along the clathrin-dependent and caveolae-mediated endocytic pathways occur simultaneously and to a similar extent. Furthermore, Rd-RF ligand buildup to caveolin 1-positive vesicles occurs at a faster rate than that for CTX and may reflect the high nutrient demands for B 2 in normal cell growth and function in the placental trophoblast cell system. Overlapping fluorescence intensities between ligands and endosome markers were further examined for 3D shape similarities using the Pearson's correlation (PC) statistical test ]TF for 4 min at 37°C and examined for membrane-associated and internalized ligands. Ratios were defined for plasma membrane-bound over internalized B 2 (A) and TF (B). The effects of dynamin 2 expression vectors or GTPase-null dynamin 2 cotransfections with DNM2 siRNA on ligand localization were defined through comparisons with single transfections with an empty vector or empty vector cotransfections with 40 nM N siRNA, respectively. These data represent the standard deviations of three to four separate experiments. Statistical significance between experimental treatments and control conditions were determined using one-way ANOVA with Newman-Keuls multiple comparison test ‫,ء(‬ p Ͻ 0.05; ‫,ءء‬ p Ͻ 0.01).
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at ASPET Journals on April 2, 2017 molpharm.aspetjournals.org Downloaded from (Manders et al., 1993) . This test is commonly used to reveal linear relationships existing between colocalized objects. Values Ͼ0.0 define positive overlap between fluorescent channels, whereas values of 0.0 or Ͻ0.0 are interpreted as no and negative correlations, respectively. Similar to the control ligands, Rd-RF revealed positive fluorescence signal overlap with both endocytic markers for both time points (Fig. 7B) and thus further suggests simultaneous ligand enrichment to these distinct endosomal populations. It is interesting that a nearly 2-fold higher PC value was defined for the 2-min uptake period versus the 10-min time point for Rd-RF overlap with clathrin. This is in agreement with prior reports that have defined the transient association of the clathrin coat proteins with nascently formed endosomes from plasma membranes (Barouch et al., 1997) . The initial stages of clathrin-mediated endocytosis from the time of ligand-bound receptor recruitment to clathrin-coated pits at the plasma membrane to the budding and release of the early endosome have been revealed to take place within 1 to 2 min across different cell systems (Schmid, 2004) . Immediately after this time, the clathrin coat dissociates from the endosome surface and is free to reassociate along the cytoplasmic face of the plasma membrane to recruit more ligand-bound receptors into the cell. The fact that we do not observe similar trends with the CME ligand transferrin may reflect a faster rate of ligand internalization and recycling that has been documented in prior reports (Dautry-Varsat et al., 1983) and may be more fully appreciated using real-time imaging methods. Unlike clathrin, caveolin 1 is an integral membrane protein coat that remains with newly formed endosomes from the cell surface. Therefore, the similar PC values revealed for both time points representing Rd-RF and CTX overlap with CAV1 would be expected. Overall, the data from these fluorescence colocalization studies suggest that Rd-RF intracellular trafficking in human placental trophoblasts occurs simultaneously and to a similar extent through distinct endocytic pathways requiring clathrin and caveolin 1.
Discussion
A dual approach involving RNAi and wild-type or dominant-negative plasmid transfections was carried out to delineate the involvement of the conserved endocytic mechanoenzyme dynamin 2 in B 2 absorption in the human placental trophoblast model BeWo. We showed that the endocytosis of B 2 is regulated, in part, by the functional expression of dynamin 2 GTPase. The extent of dynamin 2-dependence in regulating cellular B 2 levels was similar to that of the clathrin-dependent RME ligand, transferrin. Attenuated internalization of both B 2 and TF (ϳ60 and 70% of control conditions, respectively) correlated with ϳ80% reduced dynamin 2 levels. Thus, at least 50% of actively absorbed B 2 is estimated to involve a dynamin 2-dependent RME process. In addition, reductions in ligand uptake under these same conditions revealed a concomitant increase in B 2 and TF binding along the cell surface. In further support of the siRNA treatments alone, cotransfection results involving the GTPase-null dynamin 2 expression construct and DNM2 pool siRNA generated an amplified effect on the predominant ligand accumulation at the plasma membrane for both ligands. Although a B 2 -specific receptor and the proposed B 2 -soluble carrier protein remain to be identified, these data provide the most substantial evidence to date supporting the existence of such molecular machinery in humans.
Transferrin uptake in BeWo cells under silenced dynamin 2 protein expression is less pronounced compared with other reports (Hinrichsen et al., 2003; Huang et al., 2004) ; however, this observation may be cell type-and transfection reagent-specific. For instance, Huang and coworkers (2004) revealed ϳ70 to 80% inhibition in transferrin absorption in HeLa cells that were transfected twice with siRNA targeting the clathrin heavy chain (i.e., a major protein component required in clathrin polyhedral lattice formation) or dynamin 2. However, two consecutive transfections using the DNM2 pool siRNA treatments in BeWo cells drastically attenuated cell growth and compromised cell morphology when examined under light microscopy (data not shown). In another study by Soulet and colleagues (2005) , a single siRNA transfection in HeLa cells using siRNA targeting sorting nexin 9, a protein that binds and regulates dynamin 2 activity and clathrin-mediated endocytic efficiency, resulted in 45% reduction in transferrin absorption. These data are comparable with the effects we observed for this control ligand in BeWo cells treated with DNM2 pool siRNA (i.e., 30% reduced transferrin uptake). This close agreement between our results in BeWo and that of Soulet and coworkers' studies in HeLa suggests that our RNAi strategies are specific and effective in eliciting functional effects on the trafficking of the control ligand, transferrin. 
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Our laboratory recently showed a clathrin-mediated endocytic component regulating riboflavin absorption and trafficking in divergent cell systems Swaan, 2000, 2001; Huang et al., 2003; D'Souza et al., 2006b) . Based on our results that showed the requirement for dynamin 2 expression in directing B 2 cellular entry and considering the pluripotent nature of this scission enzyme on regulating different RME mechanisms, the question remained as to whether multiple and distinct endocytic pathways were regulating intracellular B 2 trafficking. The caveolae-mediated endocytic mechanism is a candidate pathway that, like CME, requires dynamin 2 activity to allow for endocytic vesicle release of ligand-receptor cargo from the plasma membrane. Established fluorescent ligand endocytosis assays involving the characterized rhodamine-B 2 conjugate were carried out to define the extent of colocalized signal intensities with the immunofluorescence detected caveolar endosome marker protein, caveolin 1, and were compared with colocalization assessments between the B 2 conjugate and clathrin-positive vesicles. Three-dimensional confocal laser scanning microscopic analyses revealed similar extents in B 2 localization to both clathrin-and caveolin 1-positive vesicles after 2-and 10-min uptake periods. In addition to this vitamin's dependence on clathrin-mediated endocytosis, the intracellular distribution of absorbed B 2 in human epithelia is implicated to involve for the first time the caveolar-mediated pathway.
The concept of multiple endocytic processes regulating the cellular trafficking of a single ligand is not unique to B 2 . Evidence of this phenomenon has been demonstrated for folate, TGF-␤, and cholera toxin subunit B (Di Guglielmo et al., 2003; Shajahan et al., 2004; Birn, 2006) . Considering the importance of maintaining cellular B 2 levels required for normal growth and development, the existence of multiple cellular transport mechanisms would provide additional controls to meet such nutritional demands in states of physiological distress. In the case for TGF-␤, Di Guglielmo and colleagues (2003) demonstrated a biochemical feedback mechanism regulating its internalization via either the clathrin-mediated or caveolar-mediated pathways. Specifically, their data revealed the absorption of TGF-␤ along the CME pathway correlated with a signal transduction response as defined by interactions with the Smad anchor for receptor activation protein. In contrast, caveolae-mediated endocytosis of TGF-␤ was coupled with the Smad7-Smurf2-dependent receptor degradation response and led to ubiquitin-dependent degradation of the TGF-␤ receptor. In this particular instance, the CvME mechanism seems to be involved in receptor degradation and ultimately receptor turnover, whereas the CME pathway functions in promoting signal transduction cascades. However, studies with epidermal growth factor (de Melker et al., 2001 ) have shown the CME pathway to facilitate receptor degradation through trafficking to lysosomal organelles. In the case for B 2 , the involvement of two distinct RME pathways regulating its intracellular distribution may reflect a homeostatic mechanism of molecular sensors that either promote B 2 -receptor activation coupled with increased vitamin endocytosis or initiate receptor degradation and reduced ligand uptake.
In summary, the RNAi and dynamin 2 plasmid DNA transfection data provide definitive and direct evidence that a B 2 receptor-mediated endocytic mechanism exists in human placental trophoblasts. To date, dynamin 2 GTPase is the first protein identified in humans to serve as a regulator of B 2 cellular entry through RME. In addition to the clathrin- Fig. 7 . Rd-RF colocalizes with caveolin 1-positive endosomes to a similar extent as with clathrin-positive vesicles. A, overlapping (i.e., colocalized) volumes (in cubic micrometers) for ligands and endosome marker channels were expressed as a percentage of the total volume for each ligand and represent the mean Ϯ S.E.M. for three to four regions of interest. B, the PC was chosen to define the likeness in 3D shapes between overlapping ligand and vesicle marker channels. A positive value for PC reflects a positive correlation in fluorescence signal overlap. Data in this graph are expressed as the mean Ϯ S.D. for three to four regions of interest.
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at ASPET Journals on April 2, 2017 molpharm.aspetjournals.org Downloaded from dependent B 2 -RME process, we report for the first time that B 2 trafficking involves the CvME pathway in the BeWo model. Understanding the cellular absorption and trafficking itineraries specific to B 2 will aid in future studies aimed at understanding various pathological states correlated with B 2 deficiency and opens up novel drug targeting strategies that can be designed to bypass efflux transporters to potentially improve drug bioavailability. Conceptually and empirically, such drug formulations targeting either folate or transferrin RME pathways have been successfully demonstrated (Stephenson et al., 2003; Singh et al., 2006) and further promote the feasibility of exploiting the B 2 -RME portal as an alternative drug targeting route. Furthermore, recent reports (Rao et al., 1999 (Rao et al., , 2006 revealing substantially elevated serum riboflavin carrier protein levels in patients with breast and liver cancer compared with healthy subjects propose a potential chemotherapeutic niche for such B 2 -drug targeting initiatives.
